{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:25:00Z","timestamp":1793057100506,"version":"4.5.0"},"reference-count":59,"publisher":"European Respiratory Society (ERS)","issue":"166","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2022,9,27]]},"published-print":{"date-parts":[[2022,12,31]]},"abstract":"<jats:sec><jats:title>Objective:<\/jats:title><jats:p>This COnsensus-based Standards for the selection of health measurement INstruments (COSMIN)-based systematic review aims to identify and summarise the quality of measurement properties of dyspnoea-specific patient-reported outcome measures (PROMs) for patients with interstitial lung disease (ILD), pulmonary hypertension (PH) or connective tissue diseases (CTDs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results:<\/jats:title><jats:p>Relevant articles in PubMed and Embase were screened. Based on COSMIN analysis and the Grading of Recommendations, Assessment, Development and Evaluation approach, overall rating and level of evidence were assessed to formulate recommendations. We identified 26 publications on 10 PROMs. For patients with ILD, including CTD-associated ILD, nine PROMs were evaluated, of which the Dyspnea-12 (D12), EXACT-Respiratory Symptoms Idiopathic Pulmonary Fibrosis Breathlessness subscale (ERS-IPF-B), King's Brief Interstitial Lung Disease Health Status Questionnaire breathlessness and activities subscale (KBILD-B) and the University of California San Diego Shortness of Breath Questionnaire (UCSD-SOBQ) had high-quality evidence for sufficient internal consistency, without high-quality evidence of insufficient measurement properties. We reached this same conclusion regarding the D12 for use in patients with PH, including CTD-associated PH. Most PROMs in this systematic review have moderate- or low-quality evidence on construct validity and responsiveness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Four dyspnoea-specific PROMs, D12, ERS-IPF-B, KBILD-B and UCSD-SOBQ, can be recommended for use in patients with ILD, including CTD-associated ILD. Of these four, the D12, despite the limited evidence and the lack of evidence on several important domains, is also suitable for use in patients with PH, including CTD-associated PH.<\/jats:p><\/jats:sec>","DOI":"10.1183\/16000617.0091-2022","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:40:14Z","timestamp":1671615614000},"page":"220091","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties"],"prefix":"10.1183","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-5049","authenticated-orcid":false,"given":"Jacqueline M.J.","family":"Lemmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2266-9907","authenticated-orcid":false,"given":"Madelon C.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia H.M.","family":"van den Ende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"2024102404072166000_31.166.220091.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"2024102404072166000_31.166.220091.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211448"},{"key":"2024102404072166000_31.166.220091.3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kex182","article-title":"Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group","volume":"57","author":"Jaeger","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2024102404072166000_31.166.220091.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.075721"},{"key":"2024102404072166000_31.166.220091.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f167"},{"key":"2024102404072166000_31.166.220091.6","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1093\/rheumatology\/keaa607","article-title":"Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study","volume":"60","author":"Moor","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2024102404072166000_31.166.220091.7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S2213-2600(20)30452-5","article-title":"Home monitoring for patients with ILD and the COVID-19 pandemic","volume":"8","author":"Nakshbandi","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024102404072166000_31.166.220091.8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/thoraxjnl-2013-204202","article-title":"Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials","volume":"69","author":"Saketkoo","year":"2014","journal-title":"Thorax"},{"key":"2024102404072166000_31.166.220091.9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141182"},{"key":"2024102404072166000_31.166.220091.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090372"},{"key":"2024102404072166000_31.166.220091.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.23718"},{"key":"2024102404072166000_31.166.220091.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-018-1798-3"},{"key":"2024102404072166000_31.166.220091.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"2024102404072166000_31.166.220091.14","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-009-9528-5"},{"key":"2024102404072166000_31.166.220091.15","doi-asserted-by":"crossref","unstructured":"Mokkink L , Prinsen CAC , Patrick DL et al. COSMIN Methodology for Systematic Reviews of Patient-Reported Outcome Measures (PROMs) User Manual version 1.0 February. 2018. https:\/\/www.cosmin.nl\/wp-content\/uploads\/COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018.pdf.","DOI":"10.1007\/978-3-319-69909-7_2972-2"},{"key":"2024102404072166000_31.166.220091.16","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-017-1765-4"},{"key":"2024102404072166000_31.166.220091.17","unstructured":"Sch\u00fcnemann H , Brozek J , Guyatt G , et al. (eds). GRADE Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. 2013. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"2024102404072166000_31.166.220091.18","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-201581"},{"key":"2024102404072166000_31.166.220091.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.03.027"},{"key":"2024102404072166000_31.166.220091.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0693"},{"key":"2024102404072166000_31.166.220091.21","doi-asserted-by":"publisher","DOI":"10.1177\/1474515113514891"},{"key":"2024102404072166000_31.166.220091.22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.rmed.2017.11.011","article-title":"Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis","volume":"134","author":"Bacci","year":"2018","journal-title":"Respir Med"},{"key":"2024102404072166000_31.166.220091.23","doi-asserted-by":"crossref","first-page":"2101790","DOI":"10.1183\/13993003.01790-2021","article-title":"The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases","volume":"59","author":"Birring","year":"2021","journal-title":"Eur Respir J"},{"key":"2024102404072166000_31.166.220091.24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12890-019-1018-0","article-title":"Validation of the King's Brief Interstitial Lung Disease questionnaire in idiopathic pulmonary fibrosis","volume":"19","author":"Prior","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2024102404072166000_31.166.220091.25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1479972316674425","article-title":"Translation and validation of the King's Brief Interstitial Lung Disease (KBILD) questionnaire in French, Italian, Swedish, and Dutch","volume":"14","author":"Wapenaar","year":"2017","journal-title":"Chron Respir Dis"},{"key":"2024102404072166000_31.166.220091.26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12931-021-01790-0","article-title":"Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease","volume":"22","author":"Chen","year":"2021","journal-title":"Respir Res"},{"key":"2024102404072166000_31.166.220091.27","doi-asserted-by":"crossref","first-page":"14799731211033925","DOI":"10.1177\/14799731211033925","article-title":"Psychometric properties of patient reported outcome measures in idiopathic pulmonary fibrosis","volume":"18","author":"Kim","year":"2021","journal-title":"Chron Respir Dis"},{"key":"2024102404072166000_31.166.220091.28","doi-asserted-by":"crossref","first-page":"e20210172","DOI":"10.36416\/1806-3756\/e20210172","article-title":"Validation of the Brazilian Portuguese version of the University of California San Diego Shortness of Breath Questionnaire in patients with interstitial lung disease","volume":"47","author":"Silva","year":"2021","journal-title":"J Bras Pneumol"},{"key":"2024102404072166000_31.166.220091.29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00408-016-9850-y","article-title":"Health-related quality of life in patients with idiopathic pulmonary fibrosis","volume":"194","author":"Yount","year":"2016","journal-title":"Lung"},{"key":"2024102404072166000_31.166.220091.30","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/acr.20591","article-title":"Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form","volume":"63","author":"Hinchcliff","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024102404072166000_31.166.220091.31","first-page":"CR405-10","article-title":"Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis","volume":"8","author":"Baddini Martinez","year":"2002","journal-title":"Med Sci Monit"},{"key":"2024102404072166000_31.166.220091.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2004.09.013"},{"key":"2024102404072166000_31.166.220091.33","first-page":"14","article-title":"Usefulness of the culturally adapted oxygen-cost diagram in the assessment of dyspnea in Puerto Rico","volume":"34","author":"De Jes\u00fas-Berrios","year":"2015","journal-title":"P R Health Sci J"},{"key":"2024102404072166000_31.166.220091.34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-10-32"},{"key":"2024102404072166000_31.166.220091.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.3.580"},{"key":"2024102404072166000_31.166.220091.36","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1007\/s10067-021-05693-9","article-title":"Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability","volume":"40","author":"Topcu","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2024102404072166000_31.166.220091.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.06.018"},{"key":"2024102404072166000_31.166.220091.38","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.21827","article-title":"Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, San Diego, Shortness of Breath Questionnaire","volume":"65","author":"Chung","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024102404072166000_31.166.220091.39","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140143"},{"key":"2024102404072166000_31.166.220091.40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00281-2019"},{"key":"2024102404072166000_31.166.220091.41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/qjmed\/hcy102","article-title":"Visual analogue scales for interstitial lung disease: a prospective validation study","volume":"111","author":"Yates","year":"2018","journal-title":"QJM"},{"key":"2024102404072166000_31.166.220091.42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12931-020-01359-3","article-title":"Responsiveness and minimal clinically important difference of SGRQ-I and KBILD in idiopathic pulmonary fibrosis","volume":"21","author":"Prior","year":"2020","journal-title":"Respir Res"},{"key":"2024102404072166000_31.166.220091.43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/resp.12945","article-title":"A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease","volume":"22","author":"Khadawardi","year":"2017","journal-title":"Respirology"},{"key":"2024102404072166000_31.166.220091.44","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.118521"},{"key":"2024102404072166000_31.166.220091.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-001027"},{"key":"2024102404072166000_31.166.220091.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.11.009"},{"key":"2024102404072166000_31.166.220091.47","unstructured":"Fletcher CM . Modified Medical Research Council Dyspnea Scale (mMRC). 1952. https:\/\/eprovide.mapi-trust.org\/instruments\/modified-medical-research-council-dyspnea-scale Date last accessed: 12 April 2022."},{"key":"2024102404072166000_31.166.220091.48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6132.241"},{"key":"2024102404072166000_31.166.220091.49","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.3.619"},{"key":"2024102404072166000_31.166.220091.50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014490"},{"key":"2024102404072166000_31.166.220091.51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.arbr.2017.08.015","article-title":"Translation and validation of the multidimensional Dyspnea-12 questionnaire","volume":"54","author":"Amado Diago","year":"2018","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"2024102404072166000_31.166.220091.52","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/COPD.S145048","article-title":"Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire","volume":"13","author":"Beaumont","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102404072166000_31.166.220091.53","unstructured":"Moosavi SH , Shuldham C , Yorke J , et al. D-12 described in ePROVIDE. 2010. https:\/\/eprovide.mapi-trust.org\/instruments\/dyspnea-12 Date last accessed: 12 April 2022."},{"key":"2024102404072166000_31.166.220091.54","unstructured":"FACIT Group . FACIT-Dyspnea Languages. www.facit.org\/measure-languages\/FACIT-Dyspnea-Languages Date last accessed: 12 April 2022."},{"key":"2024102404072166000_31.166.220091.55","unstructured":"Birring S . King's Brief Interstitial Lung Disease Questionnaire (KBILD). 2012. www.kbild.com Date last accessed: 12 April 2022."},{"key":"2024102404072166000_31.166.220091.56","first-page":"135","article-title":"Adaptation of the Medical Research Council Dyspnea Scale and the Oxygen Cost Diagram for its use in Puerto Rico","volume":"26","author":"Serrano","year":"2007","journal-title":"P R Health Sci J"},{"key":"2024102404072166000_31.166.220091.57","unstructured":"Mapi Research Trust . The University of California, San Diego Shortness of Breath Questionnaire (SOBQ) 2022. https:\/\/eprovide.mapi-trust.org\/instruments\/the-university-of-california-san-diego-shortness-of-breath-questionnaire Date last accessed: 12 April 2022."},{"key":"2024102404072166000_31.166.220091.58","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.202105-1193ST","article-title":"Patient-centered outcomes research in interstitial lung disease: an Official American Thoracic Society research statement","volume":"204","author":"Aronson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404072166000_31.166.220091.59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62227-8"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0091-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:05:34Z","timestamp":1740373534000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0091-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":59,"journal-issue":{"issue":"166","published-online":{"date-parts":[[2022,12,21]]},"published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1183\/16000617.0091-2022"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0091-2022","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]}}}